Insurers balk at multibillion-dollar claims faced by OpenAI and Anthropic

2025-10-08 · Source: Financial Times

Summary in 3 Points • Insurers face multibillion-dollar claims • OpenAI and Anthropic financial risk assessment challenges • Artificial intelligence risk scale uncertain --- Insurers are currently grappling with the potential for multibillion-dollar claims stemming from the operations of **OpenAI** and **Anthropic**, two leading companies in the field of **artificial intelligence**. The complexity and novelty of AI-related risks have made it difficult for these companies to accurately assess the financial implications and potential liabilities associated with their technologies. This uncertainty is causing significant concern among insurers, who are hesitant to provide coverage without a clear understanding of the scale and nature of these risks. For the London Insurance Market, this situation highlights the pressing need for enhanced **risk assessment** methodologies tailored to the unique challenges posed by **artificial intelligence**. As AI technologies continue to evolve, underwriters and brokers must develop a deeper understanding of the potential liabilities and exposures associated with these innovations. This could lead to a reevaluation of current **insurance models** and the development of new products designed to address the specific risks of AI. The ongoing struggle to quantify AI-related risks underscores the importance of collaboration between insurers and tech companies to ensure comprehensive coverage and risk management strategies.

London market impact

For the London Insurance Market, this situation highlights the pressing need for enhanced risk assessment methodologies tailored to the unique challenges posed by artificial intelligence. As AI technologies continue to evolve, underwriters and brokers must develop a deeper understanding of the potential liabilities and exposures associated with these innovations. This could lead to a reevaluation of current insurance models and the development of new products designed to address the specific risks of AI.